No Change in Executive/Major Shareholder Holdings


  • The filed report is a standard form for reporting ownership of specific securities by executives and major shareholders, but all fields are blank, indicating no actual changes.

KOSPI Filing Information


  • Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Hanall Biopharma (009420)
  • Submission: An Hye-kyeong

  • Shares: 52,240,638
  • Price: 46,300 KRW
  • Market Cap: 2,418.7 B KRW